# C_2014227EN.01002101.xml

| 17.7.2014 | EN | Official Journal of the European Union | C 227/21 |
| --- | --- | --- | --- |

17.7.2014

EN

Official Journal of the European Union

C 227/21

---

Prior notification of a concentration

(Case M.7323 — Nordic Capital / GHD Verwaltung)

(Text with EEA relevance)

2014/C 227/14

| 1. | On 10 July 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Nordic Capital VIII Limited (‘Nordic Capital’, Jersey), part of Nordic Capital Funds, acting in its capacity as general partner for and on behalf of Nordic Capital VIII Alpha, L.P. and Nordic Capital VIII Beta L.P., acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of the undertaking GHD Verwaltung GesundHeits GmbH Deutschland (‘GHD’, Germany) and its direct and indirect subsidiaries, by way of purchase of shares. |
| --- | --- |

1.

On 10 July 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Nordic Capital VIII Limited (‘Nordic Capital’, Jersey), part of Nordic Capital Funds, acting in its capacity as general partner for and on behalf of Nordic Capital VIII Alpha, L.P. and Nordic Capital VIII Beta L.P., acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of the undertaking GHD Verwaltung GesundHeits GmbH Deutschland (‘GHD’, Germany) and its direct and indirect subsidiaries, by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:
  —   for Nordic Capital Funds: private equity house with portfolio companies active in Europe in a wide range of sectors, including production and sale of ostomy and wound care products,
  —   for GHD: active in Europe within the production of ostomy products, compounded pharmaceuticals, the provision of logistics services, the wholesale of medical devices and pharmaceuticals and the provision of medical devices and certain pharmaceutical products to non-hospitalised patients in Germany. |
| --- | --- |

2.

The business activities of the undertakings concerned are:

—   for Nordic Capital Funds: private equity house with portfolio companies active in Europe in a wide range of sectors, including production and sale of ostomy and wound care products,

for Nordic Capital Funds

—   for GHD: active in Europe within the production of ostomy products, compounded pharmaceuticals, the provision of logistics services, the wholesale of medical devices and pharmaceuticals and the provision of medical devices and certain pharmaceutical products to non-hospitalised patients in Germany.

for GHD

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7323 — Nordic Capital / GHD Verwaltung, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7323 — Nordic Capital / GHD Verwaltung, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---